Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Toyoaki Hida"'
Publikováno v:
Oncology Letters
The resistance mechanisms to anaplastic lymphoma kinase (ALK) inhibitors comprise ALK gene variations, such as ALK point mutations and copy-number gains, the activation of bypass signaling through the activation of other oncogenes and small cell lung